Copyright & Licensing | Advanced Drug Sciences

About Journal

Advanced Drug Sciences (ADS) is an international, peer-reviewed Gold Open Access journal published by Universitas Muhammadiyah Surakarta (UMS), Indonesia. The journal is dedicated to advancing the science of drug discovery, development, and therapeutic application by publishing high-quality, original, and interdisciplinary research.

ADS provides a multidisciplinary platform that integrates pharmaceutical, biomedical, and clinical sciences, with a strong emphasis on mechanistic understanding, technological innovation, and translational relevance.

The journal aims to bridge the continuum from molecular design and formulation to clinical outcomes and population-level health impact.

The journal operates under a Gold Open Access model, ensuring that all accepted articles are immediately and permanently accessible without subscription barriers. Articles are published under a continuous publication model to enable rapid dissemination of scientific findings.

ADS welcomes contributions that advance both fundamental knowledge and practical applications in drug sciences, including, but not limited to, drug discovery and medicinal chemistry, pharmaceutics and advanced drug delivery, pharmacology and pharmacokinetics, biopharmaceuticals and biotechnology-derived therapeutics, and clinical and translational research.

Through rigorous peer review and adherence to internationally recognized ethical standards, ADS is committed to publishing scientifically robust research that contributes to innovation in drug development and the improvement of global healthcare outcomes.

All articles published in Advanced Drug Sciences (ADS) are open access and made freely available immediately upon publication.

Copyright

Authors retain full copyright of their work without restriction.

License

All articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

This license permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided that appropriate credit is given to the original authors and the source.

For full license details, please visit: https://creativecommons.org/licenses/by/4.0/

This work is licensed under a Creative Commons Attribution 4.0 International License.